Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Joseph

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Computers and Biomedical Research, an International Journal|August 1, 1980
Profile of a dictionary compiled from scanning over one million words of surgical pathology narrative textR L Wong, J D Reno, T C Hain, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1998
Carcinoembryonic antigen in breast nipple aspirate fluidL Foretova, J E Garber, N L Sadowsky, et al.
American Heart Journal|December 2, 2000
Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary interventionJ C O'shea, M Madan, W J Cantor, et al.
The Journal of Biological Chemistry|January 26, 1996
Comparison of primary charge separation in the photosystem II reaction center complex isolated from wild-type and D1-130 mutants of the cyanobacterium Synechocystis PCC 6803L B Giorgi, P J Nixon, S A Merry, et al.
Circulation|July 27, 2001
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUITB E Tardiff, L K Jennings, R A Harrington, et al.
Circulation|August 16, 2000
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic diseaseR A Harrington, P W Armstrong, C Graffagnino, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Computers and Biomedical Research, an International Journal|August 1, 1980
Profile of a dictionary compiled from scanning over one million words of surgical pathology narrative textR L Wong, J D Reno, T C Hain, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1998
Carcinoembryonic antigen in breast nipple aspirate fluidL Foretova, J E Garber, N L Sadowsky, et al.
American Heart Journal|December 2, 2000
Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary interventionJ C O'shea, M Madan, W J Cantor, et al.
The Journal of Biological Chemistry|January 26, 1996
Comparison of primary charge separation in the photosystem II reaction center complex isolated from wild-type and D1-130 mutants of the cyanobacterium Synechocystis PCC 6803L B Giorgi, P J Nixon, S A Merry, et al.
Circulation|July 27, 2001
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUITB E Tardiff, L K Jennings, R A Harrington, et al.
Circulation|August 16, 2000
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic diseaseR A Harrington, P W Armstrong, C Graffagnino, et al.
Pageof 3